1. Home
  2. HTOO vs KPRX Comparison

HTOO vs KPRX Comparison

Compare HTOO & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fusion Fuel Green PLC

HTOO

Fusion Fuel Green PLC

HOLD

Current Price

$3.39

Market Cap

7.0M

Sector

Utilities

ML Signal

HOLD

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

HOLD

Current Price

$2.16

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTOO
KPRX
Founded
2020
1998
Country
Ireland
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
8.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HTOO
KPRX
Price
$3.39
$2.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
33.8K
77.9K
Earning Date
02-28-2023
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,024,662.00
N/A
Revenue This Year
$4,832.46
N/A
Revenue Next Year
$81.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
105.98
N/A
52 Week Low
$2.92
$1.77
52 Week High
$19.18
$4.18

Technical Indicators

Market Signals
Indicator
HTOO
KPRX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
HTOO
KPRX

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: